News

Published on 28 Oct 2022 on Insider Monkey via Yahoo Finance

10 Best Pharma Dividend Stocks To Buy


Article preview image

In this article, we discuss 10 best pharma dividend stocks to buy. If you want to see more stocks in this selection, check out 5 Best Pharma Dividend Stocks To Buy. 

As per a Bloomberg report dated September 12, the global bio-pharma market was valued at $274.10 billion in 2020 and is forecasted to reach $703.28 billion by 2027 with a CAGR of 12.5% over the forecast period. The factors which will contribute to the growth of the pharma sector include the heightening prevalence of chronic diseases, increasing investment in research and development, and the growing pharmaceutical innovations. The global bio-pharma market will witness continuous growth on the back of higher need for vaccines with new diseases being discovered all over the world.

The outlook for the pharma industry remains positive for 2023. The industry will potentially exceed $1 trillion by next year, given that multiple last-stage clinical trials are set to be approved and hundreds of new products will be patented in 2023 and beyond. Some key trends which will shape the pharmaceutical industry in 2023 include the use of artificial intelligence, the acceptance of cannabidiol (CBD) for medical purposes, precision medicine, the use of blockchain technology in the pharmaceutical industry, smaller manufacturing facilities, digitization, state-mandated discounts and rebates, and an increased focus on research and development. Nearly 38% of market experts anticipate big data to have the highest impact on the pharmaceutical industry.

NASDAQ.GBIO price evolution
OTC.RVIC price evolution
NASDAQ.WBA price evolution
NYSE.MYE price evolution
LSE.APH price evolution
NYSE.CAH price evolution
NYSE.BMY price evolution
NASDAQ.AMGN price evolution

Want to become a better investor?

Start tracking your investments with Statfolio

Sign up for free
Related News
Can Generation Bio Co. (GBIO) Climb 184% to Reach the Level Wall Street Analysts Expect?

Shares of Generation Bio Co. (GBIO) have gained 0.5% over the past four weeks to close the last t...

Zacks via Yahoo Finance 5 Dec 2022

10 Best Pharma Dividend Stocks To Buy

In this article, we discuss 10 best pharma dividend stocks to buy. If you want to see more stocks...

Insider Monkey via Yahoo Finance 28 Oct 2022

11 Best Nano-Cap Stocks To Buy For 2022

In this article, we will look at the 11 best nano-cap stocks to buy for 2022. If you want to expl...

Insider Monkey via Yahoo Finance 17 Oct 2022

Beyond Meat to lay off 200 staff, shake up exec team, as it targets cash flow positive operations in...

In an SEC filing the beleaguered firm - which posted a net loss of $97.1m on revenues down -1.6% ...

Food Navigator USA 14 Oct 2022

Forget Wordle. Here are 5 secrets to living better, longer. - The Boston Globe

Steven Austad, a bio-gerontologist at the University of Alabama at Birmingham and senior scientif...

The Boston Globe 13 Oct 2022

Will Bio-Rad & Qiagen Merge? I Can't See Any Logic To This Deal (NYSE:BIO)

According to rumors circulating this week, California-based life sciences researcher and clinical...

Seeking Alpha 12 Oct 2022

A number of insiders bought Generation Bio Co. (NASDAQ:GBIO) stock last year, which is great news...

When a single insider purchases stock, it is typically not a major deal. However, when multiple i...

Simply Wall St. via Yahoo Finance 17 Sep 2022

Generation Bio Co. (GBIO) Reports Q2 Loss, Misses Revenue Estimates

Generation Bio Co. (GBIO) came out with a quarterly loss of $0.66 per share versus the Zacks Cons...

Zacks via Yahoo Finance 4 Aug 2022

Wall Street Analysts See a 174% Upside in Generation Bio Co. (GBIO): Can the Stock Really Move This...

Generation Bio Co. (GBIO) closed the last trading session at $7.38, gaining 29.7% over the past f...

Zacks via Yahoo Finance 11 Jul 2022

Legendary Value Investor Seth Klarman is Buying These 10 Stocks

In this article, we discuss 10 stocks legendary value investor Seth Klarman is buying. If you wan...

Insider Monkey via Yahoo Finance 23 May 2022